FTC moves to block $27.8B Amgen-Horizon deal



The United States Federal Trade Commission took legal action on Tuesday to prevent the $27.8 billion acquisition of Horizon Therapeutics plc by Amgen Inc. from materializing.

The potential merger &qu…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento